NCT00221572

Brief Summary

Measurement of bone density of Cystic Fibrosis patients with two techniques and correlation to serum bone parameters, use of steroids, lung function and nutritional status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2005

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 22, 2005

Completed
8 months until next milestone

Study Start

First participant enrolled

June 1, 2006

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2011

Completed
Last Updated

December 16, 2022

Status Verified

December 1, 2022

Enrollment Period

5 years

First QC Date

September 12, 2005

Last Update Submit

December 15, 2022

Conditions

Cystic Fibrosis

Interventions

Determination of bot density of Cystic Fibrosis patientsPROCEDURE

Determination of bot density of Cystic Fibrosis patients.

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Cystic Fibrosis

You may qualify if:

  • Patients with Cystic Fibrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Links

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Officials

  • Stephanie Van Biervliet, MD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 22, 2005

Study Start

June 1, 2006

Primary Completion

June 16, 2011

Study Completion

June 16, 2011

Last Updated

December 16, 2022

Record last verified: 2022-12

Locations

BE(1)